HTIM
DGX icon

Harbour Trust & Investment Management’s Quest Diagnostics DGX Stock Holding History

Harbour Trust & Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Buy
+1,000
New +$196K 0.02% 156
2024
Q1 		– Sell
-1,648
Closed -$227K – 163
2023
Q4 		$227K Buy
+1,648
New +$217K 0.03% 155

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Harbour Trust & Investment Management's DGX Position: Q2 2026 in Review

Harbour Trust & Investment Management opened a new position in Quest Diagnostics (DGX) in Q2 2026: 1,000 shares worth $212K. The stake represents 0.02% of the portfolio and ranks #156 among its holdings. This is a return to the name: Harbour Trust & Investment Management previously reported a position in DGX as recently as Q4 2023.

Harbour Trust & Investment Management first reported a position in DGX in Q4 2023 and has held it in 2 quarters since. The position peaked at $227K in Q4 2023. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Harbour Trust & Investment Management held 1,000 shares of Quest Diagnostics worth $212K as of Q2 2026.
  • Quest Diagnostics was a new Harbour Trust & Investment Management position in Q2 2026.
  • Quest Diagnostics made up 0.02% of Harbour Trust & Investment Management's portfolio in Q2 2026, its #156 holding.
  • Harbour Trust & Investment Management first reported a position in Quest Diagnostics in Q4 2023 and has held it in 2 quarters since.
  • Harbour Trust & Investment Management's Quest Diagnostics position peaked at $227K in Q4 2023.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Harbour Trust & Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.